These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20010714)

  • 1. Advances in PET analyses of stress and dopamine.
    Mizrahi R
    Neuropsychopharmacology; 2010 Jan; 35(1):348-9. PubMed ID: 20010714
    [No Abstract]   [Full Text] [Related]  

  • 2. Preliminary data indicating a connection between stress-induced prefrontal dopamine release and hippocampal TSPO expression in the psychosis spectrum.
    Schifani C; Hafizi S; Tseng HH; Gerritsen C; Kenk M; Wilson AA; Houle S; Rusjan PM; Mizrahi R
    Schizophr Res; 2019 Nov; 213():80-86. PubMed ID: 30409695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated Striatal Dopamine Function in Immigrants and Their Children: A Risk Mechanism for Psychosis.
    Egerton A; Howes OD; Houle S; McKenzie K; Valmaggia LR; Bagby MR; Tseng HH; Bloomfield MA; Kenk M; Bhattacharyya S; Suridjan I; Chaddock CA; Winton-Brown TT; Allen P; Rusjan P; Remington G; Meyer-Lindenberg A; McGuire PK; Mizrahi R
    Schizophr Bull; 2017 Mar; 43(2):293-301. PubMed ID: 28057720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased stress-induced dopamine release in psychosis.
    Mizrahi R; Addington J; Rusjan PM; Suridjan I; Ng A; Boileau I; Pruessner JC; Remington G; Houle S; Wilson AA
    Biol Psychiatry; 2012 Mar; 71(6):561-7. PubMed ID: 22133268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No evidence for attenuated stress-induced extrastriatal dopamine signaling in psychotic disorder.
    Hernaus D; Collip D; Kasanova Z; Winz O; Heinzel A; van Amelsvoort T; Shali SM; Booij J; Rong Y; Piel M; Pruessner J; Mottaghy FM; Myin-Germeys I
    Transl Psychiatry; 2015 Apr; 5(4):e547. PubMed ID: 25871972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stress-induced dopamine release in humans at risk of psychosis: a [11C]raclopride PET study.
    Soliman A; O'Driscoll GA; Pruessner J; Holahan AL; Boileau I; Gagnon D; Dagher A
    Neuropsychopharmacology; 2008 Jul; 33(8):2033-41. PubMed ID: 17957215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neural correlates of head restraint: Unsolicited neuronal activation and dopamine release.
    Inubushi T; Ito M; Mori Y; Futatsubashi M; Sato K; Ito S; Yokokura M; Shinke T; Kameno Y; Kakimoto A; Kanno T; Okada H; Ouchi Y; Yoshikawa E
    Neuroimage; 2021 Jan; 224():117434. PubMed ID: 33039616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stress-induced cortical dopamine response is altered in subjects at clinical high risk for psychosis using cannabis.
    Schifani C; Pruessner J; Tseng HH; Rao N; Tagore A; Wilson AA; Houle S; Rusjan PM; Mizrahi R
    Addict Biol; 2020 Jul; 25(4):e12812. PubMed ID: 31389139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D1-Dopamine Receptor Availability in First-Episode Neuroleptic Naive Psychosis Patients.
    Stenkrona P; Matheson GJ; Halldin C; Cervenka S; Farde L
    Int J Neuropsychopharmacol; 2019 Jul; 22(7):415-425. PubMed ID: 30958880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired Prefrontal Cortical Dopamine Release in Schizophrenia During a Cognitive Task: A [11C]FLB 457 Positron Emission Tomography Study.
    Rao N; Northoff G; Tagore A; Rusjan P; Kenk M; Wilson A; Houle S; Strafella A; Remington G; Mizrahi R
    Schizophr Bull; 2019 Apr; 45(3):670-679. PubMed ID: 29878197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daily-life stress differentially impacts ventral striatal dopaminergic modulation of reward processing in first-degree relatives of individuals with psychosis.
    Kasanova Z; Ceccarini J; Frank MJ; van Amelsvoort T; Booij J; Heinzel A; Mottaghy FM; Myin-Germeys I
    Eur Neuropsychopharmacol; 2018 Dec; 28(12):1314-1324. PubMed ID: 30482598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET study of D(1) dopamine receptor binding in neuroleptic-naive patients with schizophrenia.
    Karlsson P; Farde L; Halldin C; Sedvall G
    Am J Psychiatry; 2002 May; 159(5):761-7. PubMed ID: 11986129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Striatal and extrastriatal dopamine release in the common marmoset brain measured by positron emission tomography and [(18)F]fallypride.
    Ota M; Ogawa S; Kato K; Masuda C; Kunugi H
    Neurosci Res; 2015 Dec; 101():1-5. PubMed ID: 26232153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone.
    Mamo D; Kapur S; Shammi CM; Papatheodorou G; Mann S; Therrien F; Remington G
    Am J Psychiatry; 2004 May; 161(5):818-25. PubMed ID: 15121646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A PET study evaluating dopamine D2 receptor occupancy for long-acting injectable risperidone.
    Remington G; Mamo D; Labelle A; Reiss J; Shammi C; Mannaert E; Mann S; Kapur S
    Am J Psychiatry; 2006 Mar; 163(3):396-401. PubMed ID: 16513859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salivary kynurenic acid response to psychological stress: inverse relationship to cortical glutamate in schizophrenia.
    Chiappelli J; Rowland LM; Notarangelo FM; Wijtenburg SA; Thomas MAR; Pocivavsek A; Jones A; Wisner K; Kochunov P; Schwarcz R; Hong LE
    Neuropsychopharmacology; 2018 Jul; 43(8):1706-1711. PubMed ID: 29728648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [PET (positron emission tomography) research on schizophrenia].
    Takano A; Suhara T
    Nihon Yakurigaku Zasshi; 2006 Sep; 128(3):177-83. PubMed ID: 16971782
    [No Abstract]   [Full Text] [Related]  

  • 18. In vivo D2 dopamine receptor density in psychotic and nonpsychotic patients with bipolar disorder.
    Pearlson GD; Wong DF; Tune LE; Ross CA; Chase GA; Links JM; Dannals RF; Wilson AA; Ravert HT; Wagner HN
    Arch Gen Psychiatry; 1995 Jun; 52(6):471-7. PubMed ID: 7771917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Precision psychiatry and neuroimaging: Towards improved treatment success in psychosis].
    van Hooijdonk CFM; Booij J; van de Giessen E; Selten JP; van Amelsvoort TAMJ
    Tijdschr Psychiatr; 2024; 66(6):308-315. PubMed ID: 39162154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine transporter availability in drug-naïve patients with schizophrenia and later psychotic symptoms severity.
    Tseng HH; Chen KC; Chen PS; Lee IH; Chang WH; Yao WJ; Chiu NT; Yang YK
    Schizophr Res; 2017 Dec; 190():185-186. PubMed ID: 28364963
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.